×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

ÂѰױí´ïЧÀÍÏÈÈÝ

2015-07-27
|
»á¼ûÁ¿£º

×ðÁú¿­Ê±ÂѰױí´ïЧÀÍÓŵãÊÇʵÑéÖÜÆÚ¶Ì¡¢±¾Ç®µÍ¡¢²úÁ¿¸ß ¡£ÂѰױí´ïÊÇÖ¸ÓÃģʽÉúÎïÈçϸ¾ú¡¢½Íĸ¡¢¶¯Îïϸ°û»òÕßÖ²Îïϸ°û±í´ïÍâÔ´»ùÒòÂѰ׵ÄÒ»ÖÖ·Ö×ÓÉúÎïѧÊÖÒÕ ¡£ÔÚ»ùÒò¹¤³ÌÊÖÒÕÖÐÕ¼Óн¹µãְλ ¡£

×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!ÖØ×éÂѰױí´ïÓë´¿»¯Ð§ÀÍ

Ö÷Òª·½·¨£º´ó³¦¸Ë¾ú±í´ïϵͳ¡¢½Íĸ±í´ïϵͳ¡¢À¥³æÏ¸°û±í´ïϵͳ¡¢²¸È鶯Îïϸ°û±í´ïϵͳ¡¢Ö²Îïϸ°û±í´ïϵͳ

×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!

ÂѰױí´ïÓë´¿»¯£¨1£©



Ö÷Òª±í´ïϵͳÏÈÈÝ£º

×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!1¡¢Ô­ºË±í´ïϵͳ£º½«¿Ë¡»¯»ùÒò²åÈëºÏÊÊÔØÌåºóµ¼Èë´ó³¦¸Ë¾úÓÃÓÚ±í´ï´ó×ÚÂѰ×ÖʵÄÒªÁìÒ»Ñùƽ³£³ÆÎªÔ­ºË±í´ï ¡£ÕâÖÖÒªÁìÔÚÂѰ״¿»¯¡¢¶¨Î»¼°¹¦Ð§ÆÊÎöµÈ·½Ãæ¶¼ÓÐÓ¦Óà ¡£

    ×ðÁú¿­Ê±¿ÆÑÐÖ°Ô±½¨ÉèÁ˳ÉÊìµÄ´ó³¦¸Ë¾ú±í´ï¼°´¿»¯Ð§ÀÍÆ½Ì¨£¬Ìṩ°üÀ¨ÖÖÖÖÖØ×éÂѰ×ÒÔ¼°Æä¸´ºÏÎïÔڴ󳦸˾úÖеıí´ïÓë´¿»¯Ð§ÀÍ ¡£

    Ð§ÀÍÏîÄ¿£º

    ÖØ×éÖÊÁ£¹¹½¨  £»

    ÖØ×é±í´ï²âÊÔ  £»

    ¿ÉÈÜÐÔ±í´ïÌõ¼þ²âÊÔ  £»

    Ð¡¹æÄ£ÂѰױí´ïºÍ´¿»¯£¨2L×÷Óý»ù×÷Óý²úÆ·£©  £»

    ´ó¹æÄ£ÂѰױí´ïºÍ´¿»¯£¨10LÒÔÉÏ£© ¡£ 

Ô­ºË±í´ïÒ»Ñùƽ³£³ÌÐò£º»ñµÃÄ¿µÄ»ùÒò=¡·×¼±¸±í´ïÔØÌå=¡·½«Ä¿µÄ»ùÒò²åÈë±í´ïÔØÌåÖУ¨²âÐòÑéÖ¤£©=¡·×ª»¯±í´ïËÞÖ÷¾ú=¡·ÓÕµ¼°ÐÂѰ׵ıí´ï=¡·±í´ïÂÑ°×µÄÆÊÎö=¡·À©Ôö¡¢´¿»¯¡¢½øÒ»²½¼ì²â ¡£


Óŵ㣺ԭºËÂѰױí´ïϵͳ¼ÈÊÇ×î³£Óõıí´ïϵͳ£¬Ò²ÊÇ×î¾­¼Ãʵ»ÝµÄÂѰױí´ïϵͳ ¡£Ô­ºËÂѰױí´ïϵͳÒԴ󳦸˾ú±í´ïϵͳΪ´ú±í£¬¾ßÓÐÒÅ´«Åä¾°ÇåÎú¡¢±¾Ç®µÍ¡¢±í´ïÁ¿¸ßºÍ±í´ï²úÆ·ÊèÉ¢´¿»¯Ïà¶Ô¼òÆÓµÈÓŵã  £»

Èõµã£ºÖ÷ÒªÊÇÂѰ×ÖÊ·­Òëºóȱ·¦¼Ó¹¤»úÖÆ£¬Èç¶þÁò¼üµÄÐγɡ¢ÂѰ×ÌÇ»ù»¯ºÍ׼ȷÕÛµþ£¬»ñµÃ¾ßÓÐÉúÎï»îÐÔµÄÂѰ׵ļ¸ÂʽÏС ¡£


×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!2¡¢½Íĸ±í´ïϵͳ£º½Íĸ±í´ïϵͳ×÷ΪһÖÖºóÆðµÄÍâÔ´ÂѰױí´ïϵͳ£¬ÓÉÓÚ¼æ¾ßÔ­ºËÒÔ¼°ÕæºË±í´ïϵͳµÄÓŵ㣬ÕýÔÚ»ùÒò¹¤³ÌÁìÓòÖлñµÃÈÕÒæÆÕ±éµÄÓ¦Óã¬Ó¦ÓôËϵͳ¿É¸ßˮƽ±í´ïÂѰ×£¬ÇÒ¾ßÓз­ÒëºóÐÞÊι¦Ð§£¬¹Ê±»ÈÏ¿ÉΪһÖÖ±í´ï´ó¹æÄ£ÂѰ׵ÄÇ¿ÓÐÁ¦µÄ¹¤¾ß ¡£

    ×ðÁú¿­Ê±¿ÆÑÐÖ°Ô±½¨ÉèÁ˳ÉÊìµÄ½Íĸ±í´ï´¿»¯Ð§ÀÍÆ½Ì¨£¬ÌṩÓÅÖʵÄÖØ×éÂѰ×Ôڱϳà½ÍĸºÍÄð¾Æ½ÍĸÖеıí´ïÓë´¿»¯Ð§ÀÍ ¡£

    Ð§ÀÍÏîÄ¿£º

    ÖØ×é½Íĸ±í´ïÖÊÁ£¹¹½¨  £»

    ÖØ×éÖÊÁ£µçת»¯  £»

    ÖØ×é±í´ï×ÓɸÑ ¡  £»

    Ð¡¹æÄ£ÂѰױí´ïºÍ´¿»¯£¨2L×÷Óý»ù×÷Óý²úÆ·£©  £»

    ´ó¹æÄ£ÂѰױí´ïºÍ´¿»¯£¨10LÒÔÉÏ£© ¡£ 

Óŵ㣺½ÍĸÂѰױí´ïϵͳÒÔ¼×´¼±Ï³à½ÍĸΪ´ú±í£¬¾ßÓбí´ïÁ¿¸ß£¬¿ÉÓÕµ¼£¬ÌÇ»ù»¯»úÖÆ¿¿½ü¸ßµÈÕæºËÉúÎï£¬ÉøÍ¸ÂѰ×Ò×´¿»¯£¬Ò×ʵÏÖ¸ßÃÜ·¢½ÍµÈÓŵã ¡£

Èõµã£ºÎª²¿·ÖÂѰײúÆ·Ò×½µ½â£¬±í´ïÁ¿²»¿É¿Ø ¡£


×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!3¡¢²¸È鶯Îïϸ°ûºÍÀ¥³æÏ¸°û±í´ïϵͳ£º²¸È鶯Îïϸ°û±í´ïÍâÔ´ÖØ×éÂѰ׿ÉʹÓÃÖÊÁ£×ªÈ¾ºÍ²¡¶¾ÔØÌåµÄѬȾ ¡£Ê¹ÓÃÖÊÁ£×ªÈ¾»ñµÃÎȹ̵ÄתȾϸ°ûÐ輸ÖÜÉõÖÁ¼¸¸öÔÂʱ¼ä£¬¶øÊ¹Óò¡¶¾±í´ïϵͳÔò¿É¿ìËÙѬȾϸ°û£¬ÔÚ¼¸ÌìÄÚʹÍâÔ´»ùÒòÕûºÏµ½²¡¶¾ÔØÌåÖУ¬ÓÈÆäÊÊÓÃÓÚ´Ó´ó×Ú±í´ï²úÆ·Öмì²â³öÄ¿µÄÂѰ× ¡£

Óŵ㣺ÊÇÂѰ׷­Òëºó¼Ó¹¤»úÖÆ×î¿¿½üÌåÄÚµÄ×ÔÈ»ÐÎʽ£¬×îÈÝÒ×±£´æÉúÎï»îÐÔ ¡£

Èõµã£ºÊDZí´ïÁ¿Í¨³£½ÏµÍ£¬ÎȹÌϸ°ûϵ½¨ÉèÊÖÒÕÄѶȴó£¬Éú²ú±¾Ç®¸ß ¡£


********************ÁªÏµ×ðÁú¿­Ê±*********************************

×ðÁú¿­Ê±
ÉϺ£´¨ºàáé585ºÅ,Óʱà 201200
µç»°: +86(21)5859 1500
´«Õæ:+86(21)5859 6369
E-mail: marketing@medicilon.com.cn


    Ïà¹ØÄÚÈÝÍÆ¼ö

Ïà¹ØÐÂÎÅ
²¸È鶯Îïϸ°ûÂѰױí´ïЧÀ͹«Ë¾
2015-11-30
²¸È鶯ÎïÂѰױí´ïϵͳ,¾ß±¸ÂѰ×ÕÛµþºÍ·­ÒëºóÐÞÊεĹ¦Ð§£¬Ê¹ÆäÂѰ׸ü¿¿½ü×ÔÈ»ÂѰ×£¬´Ó¶ø»ñµÃÓë×ÔÈ»ÂѰ×ÏàͬµÄÉúÎï»îÐÔ ¡£Òò´ËʹµÃ²¸È鶯Îïϸ°û±í´ïϵͳÔÚÖØ×éÂѰ×Ò©Îï£¬ÌØÊâÊÇÖÎÁÆÐÔÖØ×éµ¥¿¹Ò©ÎïµÄÑз¢ºÍÉú²úÖÐÓÐ×îΪÆÕ±éµÄÓ¦Óà ¡£
ÂѰ×Öʱí´ïÓë´¿»¯ÊµÑé
2015-07-01
½«º¬ÓÐpCspA1-ZsGreen¡¢pCspA2-ZsGreen¡¢pCspA3-ZsGreenµÄ´ó³¦¸Ë¾ú£¨E.coli£©£¬ÔÚ16¡æ±í´ï  £»º¬ÓÐpT7-ZsGreenµÄ´ó³¦¸Ë¾ú£¨E.coli£©ÔÚ37¡æÏ±í´ïÖÁOD600£½0.6ʱ£¬¼ÓÈëIPTGÓÕµ¼±í´ï£¬²»¼ÓIPTGÓÕµ¼µÄ×÷Ϊ±ÈÕÕ ¡£
°ÐÏòPXR£º×ÔÈ»²úÆ·ÑÜÉúÎïµ÷¿ØÒ©Îï´úлÐÂÕ½ÂÔ£¡±¾Ñо¿ÖÐÂѰױí´ïÓë´¿»¯Í¨¹ý×ðÁú¿­Ê±¾ÙÐÐ
2025-10-16
Nuclear receptors are ligand-activated transcription factors involved in regulating many physiologic and pathologic processes. Ligand binding to nuclear receptors leads to dissociation of co-repressors, recruitment of co-activators, and subsequent activation of gene expression. Because of their associations with many human diseases, nuclear receptors are therapeutic targets for pharmaceutical development. The pregnane X receptor (PXR, NR1I2) belongs to the nuclear receptor family. The activity of PXR can be controlled by the binding of small molecule agonists or antagonists. Because of its unique ligand binding pocket, PXR binds promiscuously to structurally diverse chemicals. PXR regulates the expression of proteins such as drug metabolizing enzyme cytochrome P450 3A4 (CYP3A4), efflux transporter P-glycoprotein, and other multidrug resistance proteins, which are involved in metabolism and elimination of potentially harmful chemicals. PXR has been detected in various tissues including kidney, colon, brain capillaries, small intestine, and predominantly in liver, and it can be activated by various ligands that bind to its ligand binding domain (LBD). PXR forms a heterodimeric complex with RXR to activate gene transcription. The recombinant pETDuet1-hPXR-LBD/mSRC-1 plasmid (Medicilon, Shanghai, China) was transformed into Escherichia coli BL21 DE3 cells for protein expression.
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿